^
+ Follow COHORT Tag 
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 637073
                    [Title] => Roche bares non-Hodgkin's lymphoma study results
                    [Summary] => 
ORLANDO, Florida — Roche announced recently new Phase II efficacy data from the investigational compound GA101 (RG 1759) in relapsed/refractory non-Hodgkin’s lymphoma (NHL), a common type of blood cancer.

                    [DatePublished] => 2010-12-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 284652
                    [Title] => Environmental factors and risk for liver cancer (hepatocellular carcinoma)
                    [Summary] => 
(Continuation)
                    [DatePublished] => 2005-07-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

COHORT
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 637073
                    [Title] => Roche bares non-Hodgkin's lymphoma study results
                    [Summary] => 
ORLANDO, Florida — Roche announced recently new Phase II efficacy data from the investigational compound GA101 (RG 1759) in relapsed/refractory non-Hodgkin’s lymphoma (NHL), a common type of blood cancer.

                    [DatePublished] => 2010-12-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 284652
                    [Title] => Environmental factors and risk for liver cancer (hepatocellular carcinoma)
                    [Summary] => 
(Continuation)
                    [DatePublished] => 2005-07-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest
                        

                           

                              
                              
Roche bares non-Hodgkin's lymphoma study results
                              


                              

                                 December 9, 2010 - 12:00am                              


                                                            
ORLANDO, Florida — Roche announced recently new Phase II efficacy data from the investigational compound GA101 (RG 1759) in relapsed/refractory non-Hodgkin’s lymphoma (NHL), a common type of blood c...

                                                         


      

         

            
Science and Environment
fbtw

      

   

                        

                        

                           

                              
                              

                              

                                 

                                    
Environmental factors and risk for liver cancer (hepatocellular carcinoma)
                                 


                                 

                                    By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | July 3, 2005 - 12:00am                                 

                              


                              
(Continuation)

                           


      

         

            
Opinion
fbtw

      

   

                        


            
         
      
    


   

   

      

         

            
               

                  

                  

                  

                  

                  

                  

                  

                  

               


               

               

                  
Are you sure you want to log out?

                  
                  
               

               

               

                  
X


                  


                  

                     
Login

                     
Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

                     

                        
Get Updated:

                        
Signup for the News Round now

                     

                  

                     

                     

                     

                     

                     

                         

                        FORGOT PASSWORD?
                     


                     
SIGN IN


                     

                        


                        

                           or sign in with